Lupin Dental

Summary

About

About Lupin Dental

Lupin Dental’s system translates a digitally planned smile and tooth-preparation workflow into supervised robotic execution at the dental chair. The workstation is designed to prepare teeth for aesthetic veneers while the clinician retains responsibility for diagnosis, treatment planning and final decisions.

The company completed its first commercial installation in India in November 2025 and received UKCA certification in June 2026. In India, the technology is licensed to Dolphin Lifesciences and manufactured and distributed as the Dolphin Robotic Dental System. Lupin Dental remains uncleared for clinical use in the United States and European Union.

PRICE
Range 1Y
Return
High
Low
Updated
DATA: KORTHOS

Articles

30 AUG 2026

Robotics capital moves — 24–30 August 2026

Funding

Investors

  • Fynveur - Lead - Unknown - 1 funding event - first seen 2026-08-27

Team

  • Paul Roberts - Chief Executive Officer and Strategic Board Member - He leads Lupin Dental through regulatory expansion and commercialization of its supervised dental-robotics platform.
  • Stéfen Koubi - Chief Medical Officer, Co-founder and Clinical Board Member - As co-founder and chief medical officer, he contributes the minimally invasive veneer workflow embedded in the Lupin Robotic System.
  • Galip Gürel - Chief Medical Officer, Co-founder and Clinical Board Member - As co-founder and chief medical officer, he contributes the aesthetic-dentistry expertise translated into the Lupin treatment workflow.
  • Karim Tourbah - Chief Product and Innovation Officer - He leads product and innovation across the treatment-planning software and robotic-workstation system.
  • Olivier Tintorini - Chief Commercial Officer - He leads commercial activity around market entry and placement of the Lupin Robotic System, including the first commercial installation in India.
  • Michel Mayer - Chairman of the Board - He chairs Lupin Dental's board and guides company strategy, partnerships and growth.

Timeline

Events

  • 2026-08-27 - Funding - Lupin Dental closes €15M Series A

    Fynveur invested €10 million; existing shareholders and new private investors also participated. The equity round is complemented by a separate Bpifrance loan, whose amount was not disclosed and is excluded from the private-funding aggregate. Invus, which advises Fynveur, will join Lupin Dental’s board as the company expands its dental-robotics operations.

    Source

Context

Comparable profiles

Shared workflows

Context tags

  • Robot-assisted procedure workflow - Workflow - Lupin develops a supervised robotic workstation that executes digitally planned tooth preparation under clinician control.
  • Surgical assistance - Workflow - The workstation assists dentists with minimally invasive veneer preparation while diagnosis and final decisions remain clinician-led.
  • Surgical navigation and planning - Capability - Planning software designs the final smile and generates the tooth-preparation plan executed by the workstation.
  • Medical robot OEM - Stack Layer - DIGICUTO develops the complete Lupin Robotic System and licenses Indian manufacture and distribution to Dolphin Lifesciences.
  • Surgical robotics platform - Stack Layer - The platform combines modular treatment-planning software with a supervised robotic workstation for clinical tooth preparation.
  • Hospitals and surgical centres - Customer Environment - Lupin's first commercial system was installed at Pharande Dental Hospital in Pune in November 2025.